<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04183322</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 1515</org_study_id>
    <nct_id>NCT04183322</nct_id>
  </id_info>
  <brief_title>PCV13 in Non-pregnant Papua New Guinean Women</brief_title>
  <official_title>Reactogenicity and Immunogenicity of Pneumococcal Conjugate Vaccination in Non-pregnant Papua New Guinean Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Telethon Kids Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Papua New Guinea Institute of Medical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Telethon Kids Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study to determine the reactogenicity and immunogenicity of
      pneumococcal conjugate vaccine in non-pregnant women of reproductive age in Papua New Guinea.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 10, 2016</start_date>
  <completion_date type="Actual">April 10, 2018</completion_date>
  <primary_completion_date type="Actual">September 14, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Immunogenicity</measure>
    <time_frame>28 days</time_frame>
    <description>Mean Fold Increase (MFI; and 95% CI) in vaccine-serotype specific IgG concentrations at 28 days after compared to baseline (before vaccination)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reactogenicity</measure>
    <time_frame>24-48 hours after vaccination</time_frame>
    <description>Proportion (% &amp; 95% CI) of participants with local and systemic side effects 24-48 hours after vaccination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>28 days</time_frame>
    <description>Proportion (% &amp; 95% CI) of participants reporting any unexpected adverse effect (AE) during 28 days after vaccination</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Pneumococcal Infections</condition>
  <arm_group>
    <arm_group_label>Women of childbearing age</arm_group_label>
    <description>Healthy non-pregnant women between 18 and 45 years old living in Goroka, Papua New Guinea, will receive one dose of 13-valent pneumococcal conjugate vaccine (PCV).</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>13-valent pneumococcal conjugate vaccine</intervention_name>
    <arm_group_label>Women of childbearing age</arm_group_label>
    <other_name>PCV13</other_name>
    <other_name>13-valent PCV</other_name>
    <other_name>Prevnar13</other_name>
    <other_name>Prevenar13</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        50 healthy non-pregnant women aged between 18-45 years old living in Goroka, Papua New
        Guinea.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Non-pregnant

          -  18-45 years old

        Exclusion Criteria:

          -  Known hypersensitivity to any vaccine component

          -  Known/suspected to be immunocompromised

          -  Receipt of corticosteroids â‰¤30 days before

          -  Pregnant (pregnancy tests will be performed)

          -  Not being well at the time of vaccination

          -  Plan to travel out of the area in the month post-vaccination
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Papua New Guinea Institute of Medical Research</name>
      <address>
        <city>Goroka</city>
        <state>Eastern Hghlands Province</state>
        <zip>441</zip>
        <country>Papua New Guinea</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Papua New Guinea</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 27, 2019</study_first_submitted>
  <study_first_submitted_qc>November 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2019</study_first_posted>
  <last_update_submitted>December 13, 2019</last_update_submitted>
  <last_update_submitted_qc>December 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pneumococcal conjugate vaccine</keyword>
  <keyword>PCV</keyword>
  <keyword>Reactogenicity</keyword>
  <keyword>Immunogenicity</keyword>
  <keyword>Women childbearing age</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumococcal Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

